X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19937) 19937
Newspaper Article (3121) 3121
Book Review (3006) 3006
Publication (1526) 1526
Newsletter (1260) 1260
Government Document (1080) 1080
Magazine Article (440) 440
Trade Publication Article (344) 344
Conference Proceeding (283) 283
Book Chapter (136) 136
Book / eBook (126) 126
Dissertation (121) 121
Web Resource (99) 99
Report (45) 45
Transcript (19) 19
Journal / eJournal (13) 13
Paper (11) 11
Data Set (6) 6
Reference (4) 4
Technical Report (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
stroke (19127) 19127
index medicus (14485) 14485
humans (14029) 14029
male (8979) 8979
female (8720) 8720
aged (7198) 7198
middle aged (6844) 6844
risk factors (5202) 5202
mortality (4300) 4300
adult (4191) 4191
aged, 80 and over (3194) 3194
rehabilitation (3145) 3145
research (3108) 3108
clinical neurology (2918) 2918
analysis (2571) 2571
medical research (2402) 2402
cardiovascular disease (2388) 2388
studies (2250) 2250
patients (2206) 2206
hypertension (2142) 2142
care and treatment (2140) 2140
stroke - epidemiology (2110) 2110
prevention (2084) 2084
peripheral vascular disease (2029) 2029
risk (2028) 2028
treatment outcome (1976) 1976
cardiac & cardiovascular systems (1955) 1955
cardiovascular diseases (1895) 1895
health aspects (1894) 1894
abridged index medicus (1885) 1885
prevalence (1870) 1870
epidemiology (1864) 1864
socioeconomic factors (1789) 1789
neurosciences (1786) 1786
medicine, general & internal (1670) 1670
population (1653) 1653
diabetes (1625) 1625
hospitals (1577) 1577
medicine (1572) 1572
disease (1514) 1514
stroke rehabilitation (1486) 1486
stroke - prevention & control (1465) 1465
risk-factors (1460) 1460
atrial fibrillation (1450) 1450
public, environmental & occupational health (1443) 1443
public health (1439) 1439
neurology (1424) 1424
quality of life (1420) 1420
health (1412) 1412
ischemia (1384) 1384
retrospective studies (1354) 1354
time factors (1325) 1325
prospective studies (1316) 1316
stroke - therapy (1308) 1308
management (1305) 1305
medicine, experimental (1302) 1302
stroke - etiology (1283) 1283
stroke - economics (1271) 1271
research article (1215) 1215
incidence (1213) 1213
cost-benefit analysis (1208) 1208
care (1174) 1174
stroke patients (1168) 1168
clinical trials (1152) 1152
ischemic-stroke (1136) 1136
cohort studies (1132) 1132
surgery (1122) 1122
health risk assessment (1121) 1121
follow-up studies (1120) 1120
outcomes (1094) 1094
blood pressure (1083) 1083
adolescent (1070) 1070
therapy (1065) 1065
young adult (1058) 1058
age (1025) 1025
stroke - mortality (1022) 1022
health care sciences & services (1007) 1007
heart attacks (997) 997
medicine & public health (997) 997
heart (986) 986
heart diseases (985) 985
women (971) 971
prognosis (969) 969
national institutes of health (966) 966
age factors (965) 965
stroke - complications (930) 930
cardiology (918) 918
risk assessment (916) 916
comorbidity (910) 910
united states (909) 909
anticoagulants (906) 906
stroke - diagnosis (889) 889
usage (886) 886
cross-sectional studies (882) 882
cardiovascular (875) 875
heart failure (866) 866
surveys and questionnaires (865) 865
activities of daily living (858) 858
brain (857) 857
cancer (857) 857
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (66) 66
Online Resources - Online (23) 23
Providence Healthcare - Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Robarts - Stacks (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
UofT at Mississauga - Stacks (4) 4
Holland Bloorview Kids Rehabilitation - Stacks (3) 3
UTL at Downsview - May be requested (3) 3
OISE - Stacks (2) 2
Providence Healthcare - Reference (2) 2
St. Michael's Hospital - Stacks (2) 2
West Park Healthcare Centre - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Knox College (Caven) - Audio Visual (1) 1
Knox College (Caven) - McKay Resource Centre (1) 1
Map & Data - Map Collection (1) 1
Providence Healthcare - Lost (1) 1
Robarts - Government Pubs (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Toronto East General Hospital - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (26112) 26112
Spanish (109) 109
Turkish (106) 106
German (100) 100
French (63) 63
Portuguese (49) 49
Russian (34) 34
Chinese (23) 23
Japanese (17) 17
Italian (11) 11
Swedish (11) 11
Hungarian (10) 10
Polish (10) 10
Korean (9) 9
Lithuanian (9) 9
Croatian (8) 8
Danish (5) 5
Dutch (5) 5
Czech (4) 4
Norwegian (4) 4
Finnish (2) 2
Hebrew (2) 2
Persian (2) 2
Indonesian (1) 1
Romanian (1) 1
Serbian (1) 1
Slovak (1) 1
Slovenian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Value in Health, ISSN 1098-3015, 2013, Volume 16, Issue 4, pp. 498 - 506
Abstract Objectives The primary objective was to assess the cost-effectiveness of new oral anticoagulants compared with warfarin in patients with nonvalvular... 
Internal Medicine | anticoagulants | cost-effectiveness | atrial fibrillation | cardiovascular | warfarin | MORTALITY | MANAGEMENT | ASPIRIN | PROPHYLAXIS | DABIGATRAN ETEXILATE | RISK-FACTOR | HEALTH CARE SCIENCES & SERVICES | HEALTH POLICY & SERVICES | ECONOMICS | Thiophenes - therapeutic use | Pyrazoles - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Warfarin - economics | Warfarin - administration & dosage | Warfarin - therapeutic use | Rivaroxaban | Atrial Fibrillation - economics | Benzimidazoles - administration & dosage | Time Factors | beta-Alanine - economics | Aged, 80 and over | Pyridones - economics | beta-Alanine - analogs & derivatives | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Quality-Adjusted Life Years | Cardiovascular Diseases - etiology | Administration, Oral | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Stroke - etiology | Hemorrhage - chemically induced | Drug Costs | Markov Chains | Age Factors | Anticoagulants - administration & dosage | Anticoagulants - economics | Thiophenes - administration & dosage | Benzimidazoles - economics | Dabigatran | Morpholines - economics | Pyridones - administration & dosage | Thiophenes - economics | Cardiovascular Diseases - economics | Stroke - prevention & control | Hemorrhage - epidemiology | Morpholines - administration & dosage | Stroke - economics | beta-Alanine - administration & dosage | beta-Alanine - therapeutic use | Pyrazoles - economics | Randomized Controlled Trials as Topic | Pyrazoles - administration & dosage | Cost-Benefit Analysis | Aged | Pyridones - therapeutic use | Index Medicus
Journal Article
European Journal of Neurology, ISSN 1351-5101, 2012, Volume 19, Issue 1, pp. 155 - 162
Journal Article
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2014, Volume 127, Issue 11, pp. 1075 - 1082.e1
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2014, Volume 63, Issue 12, pp. 1123 - 1133
Heart failure is a global pandemic affecting an estimated 26 million people worldwide and resulting in more than 1 million hospitalizations annually in both... 
acute | heart failure | registry | hospitalization | inpatient | VENTRICULAR EJECTION FRACTION | CARDIAC & CARDIOVASCULAR SYSTEMS | QUALITY-OF-CARE | OPTIMIZE-HF REGISTRY | ORGANIZED PROGRAM | EUROBSERVATIONAL RESEARCH-PROGRAM | STROKE STATISTICS-2012 UPDATE | INITIATE LIFESAVING TREATMENT | ONE-YEAR MORTALITY | PHYSICIAN FOLLOW-UP | PRESERVED SYSTOLIC FUNCTION | Age Distribution | Vasodilator Agents - therapeutic use | Anemia - epidemiology | United States | Humans | Catheterization, Swan-Ganz - utilization | Male | Dyspnea - etiology | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Electrocardiography | Female | Registries | Coronary Angiography - utilization | Heart Failure - diagnosis | Heart Failure - epidemiology | Heart Failure - etiology | Drug Utilization - statistics & numerical data | Length of Stay - statistics & numerical data | Adrenergic beta-Antagonists - therapeutic use | Hyponatremia - epidemiology | Cardiac Resynchronization Therapy - utilization | Echocardiography | Glomerular Filtration Rate | Hospital Mortality | Comorbidity | Europe | Defibrillators, Implantable - utilization | Hospitalization | Evidence-Based Medicine | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Quality Improvement | Asia | Natriuretic Peptides - analysis | Sex Distribution | Diuretics - therapeutic use | Aged | Angiotensin Receptor Antagonists - therapeutic use | Heart failure | Medical colleges | Medical research | Mortality | Therapeutics | Economic aspects | Medicine, Experimental | Natriuretic peptides | Homeopathy | Materia medica and therapeutics | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The European Journal of Health Economics, ISSN 1618-7598, 10/2013, Volume 14, Issue 5, pp. 789 - 797
Journal Article
PharmacoEconomics, ISSN 1170-7690, 6/2014, Volume 32, Issue 6, pp. 601 - 612
Atrial fibrillation is a major risk factor for stroke, which causes thousands of deaths and sequelae. It is recommended that atrial fibrillation patients at... 
Quality of Life Research | Health Economics | Health Administration | Public Health | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | PREDICTING STROKE | MORTALITY | POPULATION | COST-EFFECTIVENESS | HEART-FAILURE | RISK STRATIFICATION SCHEMES | TASK-FORCE | HEALTH CARE SCIENCES & SERVICES | PHARMACOLOGY & PHARMACY | HEALTH POLICY & SERVICES | ECONOMICS | HEALTH-CARE | THROMBOEMBOLISM | ISCHEMIC-STROKE | Thiophenes - therapeutic use | Markov Chains | Pyrazoles - therapeutic use | Humans | Anticoagulants - economics | Warfarin - economics | Benzimidazoles - economics | Dabigatran | Morpholines - economics | Warfarin - therapeutic use | Rivaroxaban | Atrial Fibrillation - economics | beta-Alanine - economics | Aged, 80 and over | Thiophenes - economics | Pyridones - economics | beta-Alanine - analogs & derivatives | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Quality-Adjusted Life Years | Stroke - prevention & control | Atrial Fibrillation - drug therapy | Risk Factors | Atrial Fibrillation - complications | Decision Support Techniques | Stroke - economics | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Models, Statistical | Anticoagulants - adverse effects | Pyrazoles - economics | Norway | Cost-Benefit Analysis | Aged | Pyridones - therapeutic use | Stroke (Disease) | Care and treatment | Usage | Abnormalities | Analysis | Anticoagulants (Medicine) | Muscle contraction | Risk factors | Studies | Cardiac arrhythmia | Anticoagulants | Markov analysis | Benefit cost analysis | Original
Journal Article
Journal Article
Diabetes Care, ISSN 0149-5992, 2014, Volume 37, Issue 5, pp. 1338 - 1345
Journal Article
Journal Article